Amylyx Pharmaceuticals Balance Sheet (2021-2026) | AMLX

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Accumulated Depreciation (Quarter)
0.05M0.54M1.63M1.36M1.55M
Assets
Current Assets
Cash & Equivalents (Quarter)
50.19M110.40M67.44M107.73M62.53M114.56M247.76M135.26M170.20M170.55M75.00M71.84M77.39M59.76M58.09M225.18M226.65M229.14M
Receivables - Net (Quarter)
0.14M15.31M17.55M33.47M29.35M40.05M20.35M4.09M1.73M0.45M0.30M0.10M0.13M0.09M
Receivables - Other (Quarter)
0.50M0.30M0.80M0.10M0.50M0.30M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M
Receivables (Quarter)
0.14M15.81M17.86M34.27M29.45M40.55M20.65M4.19M1.83M0.55M0.40M0.20M0.23M0.19M
Raw Materials (Quarter)
0.41M7.15M
Work In Process (Quarter)
0.04M1.68M
Finished Goods (Quarter)
0.11M0.94M
Inventory (Quarter)
0.56M9.77M13.07M24.86M32.37M38.32M
Prepaid Assets (Quarter)
5.39M10.28M9.46M8.34M10.11M12.75M11.79M17.34M14.93M16.89M12.82M9.14M12.48M11.78M5.96M9.26M6.69M5.26M
Current Assets (Quarter)
104.95M265.49M216.14M172.20M382.13M389.05M427.39M434.11M464.67M410.53M326.72M245.26M189.43M216.14M186.89M353.38M323.67M285.02M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.47M1.29M1.86M2.12M2.61M2.56M2.64M2.76M2.69M2.46M1.47M1.25M0.96M0.82M0.45M0.40M0.31M0.21M
Other Non-Current Assets (Quarter)
0.20M0.42M0.46M0.46M0.47M0.47M0.47M0.48M0.70M0.49M0.48M0.48M0.02M0.01M2.50M2.50M2.50M
Non-Current Assets (Quarter)
0.66M8.95M9.10M9.24M9.32M18.91M26.19M32.47M52.79M6.92M5.44M5.45M4.20M3.53M7.71M9.36M8.97M8.58M
Assets (Quarter)
105.61M274.44M225.24M181.44M391.45M407.96M453.59M466.58M517.45M417.46M332.16M250.71M193.63M219.68M194.60M362.74M332.64M293.60M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
4.37M10.04M8.12M7.05M6.26M10.77M24.70M6.37M22.06M21.45M4.96M1.49M2.94M4.81M3.29M5.34M3.52M3.53M
Payables (Quarter)
4.37M10.04M8.12M7.05M6.26M10.77M24.70M6.37M22.06M21.45M4.96M1.49M2.94M4.81M3.29M5.34M3.52M3.53M
Accumulated Expenses (Quarter)
13.02M16.26M6.48M23.61M38.31M38.75M37.24M37.05M57.72M67.87M62.76M50.46M23.95M12.07M17.46M19.47M17.91M11.28M
Other Accumulated Expenses (Quarter)
0.26M0.44M0.54M0.36M1.00M
Current Leases (Quarter)
1.41M1.79M1.99M2.04M2.09M2.15M2.20M2.26M2.31M2.37M1.97M1.52M1.05M0.67M0.98M1.26M1.16M
Total Current Liabilities (Quarter)
17.40M27.71M27.16M32.65M46.61M51.62M64.08M45.62M82.04M91.64M70.08M53.91M28.41M17.93M21.42M25.79M22.69M15.97M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
0.04M
Preferred Stock Liabilities (Quarter)
64.39M64.39M239.35M
Operating Leases (Quarter)
5.79M5.29M4.77M4.24M3.69M3.14M2.57M1.98M1.38M0.77M5.10M0.46M0.33M5.30M4.95M4.70M4.48M
Total Liabilities (Quarter)
101.89M124.07M17.43M33.49M32.45M37.41M50.85M55.31M67.22M48.18M84.02M93.02M70.85M54.51M28.87M18.26M26.72M30.75M27.39M20.44M
Shareholder's Equity
Common Equity (Quarter)
-101.89M-124.07M-151.17M240.95M192.79M144.03M340.61M352.65M386.37M418.40M433.43M324.44M261.31M196.20M164.76M201.42M167.88M332.00M305.26M273.16M
Shareholder's Equity (Quarter)
-101.89M-124.07M-151.17M240.95M192.79M144.03M340.61M352.65M386.37M418.40M433.43M324.44M261.31M196.20M164.76M201.42M167.88M332.00M305.26M273.16M
Liabilities and Shareholders Equity (Quarter)
105.61M274.44M225.24M181.44M391.45M407.96M453.59M466.58M517.45M417.46M332.16M250.71M193.63M219.68M194.60M362.74M332.64M293.60M
Retained Earnings (Quarter)
-155.84M-203.69M-0.20M-311.52M-0.09M0.03M-330.57M-309.68M0.20M-0.08M-0.10M-569.15M-606.69M-684.04M-718.43M0.40M0.24M
Treasury Shares (Quarter)
0.60M0.67M0.69M0.74M1.06M1.06M1.08M1.11M2.06M2.91M2.27M2.21M3.17M3.14M2.76M2.73M3.93M
Shares Outstanding (Quarter)
6.44M6.80M7.02M57.86M58.53M58.53M66.51M67.10M67.35M67.51M67.71M67.98M68.08M68.55M68.63M89.08M89.16M109.77M109.88M111.03M